Featured Research

from universities, journals, and other organizations

Key Component In Mammalian Telomere Maintenance Found

Date:
November 20, 2000
Source:
Cold Spring Harbor Laboratory
Summary:
Research into telomere maintenance is at the forefront of the biomedical investigation of aging and cancer. Telomeres, the specialized ends of eukaryotic chromosomes, are required for normal cell growth. Recently, a collaboration of scientists from around the country has discovered a key component in the mammalian telomere maintenance machinery. As reported in Genes & Development, Hsu and colleagues have found that the protein Ku mediates mammalian telomere capping.

Research into telomere maintenance is at the forefront of the biomedical investigation of aging and cancer. Telomeres, the specialized ends of eukaryotic chromosomes, are required for normal cell growth. Recently, a collaboration of scientists from around the country has discovered a key component in the mammalian telomere maintenance machinery. As reported in Genes & Development, Hsu and colleagues have found that the protein Ku mediates mammalian telomere capping.

Telomere capping conceals and disguises the ends of chromosomal DNA so to distinguish it from double stranded DNA breaks. Telomere capping thereby prevents the fusion of chromosome ends, an event associated with genetic instability and a hallmark in the development of cancer. The association of Ku with the mammalian telomere was, though, a surprising discovery.

Ku was originally discovered as a member of the DNA damage repair complex which repairs double stranded DNA breaks. One would expect that such proteins would be excluded from the telomeres, but that is not the case. Hsu and colleagues determined that Ku acts in a unique way at the mammalian telomere. Ku specifically binds a telomere binding protein, and is required to prevent telomere end fusion. Mouse cells that lack Ku develop numerous chromosome fusions.

Ku works at the mammalian telomere in a functionally distinct manner from its action at double stranded breaks. Understanding the surprising association of Ku with the mammalian telomere is a primary step in understanding the delicate balance of cellular growth control and the aberrations which lead to cancer.


Story Source:

The above story is based on materials provided by Cold Spring Harbor Laboratory. Note: Materials may be edited for content and length.


Cite This Page:

Cold Spring Harbor Laboratory. "Key Component In Mammalian Telomere Maintenance Found." ScienceDaily. ScienceDaily, 20 November 2000. <www.sciencedaily.com/releases/2000/11/001120073646.htm>.
Cold Spring Harbor Laboratory. (2000, November 20). Key Component In Mammalian Telomere Maintenance Found. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2000/11/001120073646.htm
Cold Spring Harbor Laboratory. "Key Component In Mammalian Telomere Maintenance Found." ScienceDaily. www.sciencedaily.com/releases/2000/11/001120073646.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins